Director/PDMR Shareholding, Issue of Ordinary S...

1 July 2020

Arix Bioscience plc

Director/PDMR Shareholding, Issue of Ordinary Shares

PDMR Notification

Arix Bioscience plc (the “Company”) today announces the annual award of nil cost options to certain members of management, all of which are subject to performance conditions over a three year assessment period, in accordance with the Company’s Remuneration Policy.

Issue of Ordinary Shares

The Company announces that it has allotted 57,803 new Ordinary Shares to Naseem Amin, Executive Chairman, in satisfaction of the commitment made upon his appointment as a Non-Executive Director in December 2019 and in accordance with the Company’s Remuneration Policy.

Application has been made for 57,803 new Ordinary Shares to be admitted to the standard segment of the Official List and to trading on the Main Market of the London Stock Exchange. The new Ordinary Shares will rank pari passu with the existing ordinary shares and it is expected that admission of these new Ordinary Shares will take place at 8.00 a.m. on 6 July 2020.

PDMR Dealing Notifications

PDMR DEALING NOTIFICATION
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Naseem Amin
2	Reason for the notification
a)	Position / status	Executive Chairman
b)	Initial notification / Amendment	Initial Notification
3	Details of issuer
a)	Name	Arix Bioscience plc
b)	LEI	213800OVT3AHQCXNIX43
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Ordinary Shares of Arix Bioscience plc
	Identification code	GB00BD045071
b)	Nature of the transaction	Award of nil-cost options under the Arix Bioscience plc Executive Incentive Plan ("EIP")
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		Nil	462,428
d)	Aggregated information	Aggregated price	Aggregated volume
		N/A (single transaction)	N/A (single transaction)
e)	Date of the transaction	30 June 2020
f)	Place of the transaction	Outside a trading venue

PDMR DEALING NOTIFICATION
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Robert Lyne
2	Reason for the notification
a)	Position / status	Chief Operating Officer
b)	Initial notification / Amendment	Initial Notification
3	Details of issuer
a)	Name	Arix Bioscience plc
b)	LEI	213800OVT3AHQCXNIX43
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Ordinary Shares of Arix Bioscience plc
	Identification code	GB00BD045071
b)	Nature of the transaction	Award of nil-cost options under the Arix Bioscience plc Executive Incentive Plan ("EIP")
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		Nil	471,676
d)	Aggregated information	Aggregated price	Aggregated volume
		N/A (single transaction)	N/A (single transaction)
e)	Date of the transaction	30 June 2020
f)	Place of the transaction	Outside a trading venue

PDMR DEALING NOTIFICATION
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Marcus Karia
2	Reason for the notification
a)	Position / status	Group Finance Director
b)	Initial notification / Amendment	Initial Notification
3	Details of issuer
a)	Name	Arix Bioscience plc
b)	LEI	213800OVT3AHQCXNIX43
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Ordinary Shares of Arix Bioscience plc
	Identification code	GB00BD045071
b)	Nature of the transaction	Award of nil-cost options under the Arix Bioscience plc Executive Incentive Plan ("EIP")
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		Nil	389,133
d)	Aggregated information	Aggregated price	Aggregated volume
		N/A (single transaction)	N/A (single transaction)
e)	Date of the transaction	30 June 2020
f)	Place of the transaction	Outside a trading venue

PDMR DEALING NOTIFICATION
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Naseem Amin
2	Reason for the notification
a)	Position / status	Executive Chairman
b)	Initial notification / Amendment	Initial Notification
3	Details of issuer
a)	Name	Arix Bioscience plc
b)	LEI	213800OVT3AHQCXNIX43
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Ordinary Shares of Arix Bioscience plc
	Identification code	GB00BD045071
b)	Nature of the transaction	Award of Ordinary Shares
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		£0.8650	57,803
d)	Aggregated information	Aggregated price	Aggregated volume
		N/A (single transaction)	N/A (single transaction)
e)	Date of the transaction	30 June 2020
f)	Place of the transaction	London Stock Exchange (XLON)

For further information please contact:

Robert Lyne  Chief Operating Officer  [phone]

 - Ends -